Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/24/2012CN102743751A Preparation method of newcastle diseases, infectious bursal disease bigeminy high immunity-yolk-antibody lyophilized powder
10/24/2012CN102743750A Compound immunoenhancement agent, vaccine for birds and method for preparing compound immunoenhancement agent
10/24/2012CN102743749A Method for preparing live attenuated rubella vaccine in human diploid cells by using basket-type bioreactor
10/24/2012CN102743748A Method for preparing swine fever live vaccine by using oscillatory type bioreactor
10/24/2012CN102743747A Use of alpha-toxin for treating and preventing staphylococcus infections
10/24/2012CN102743746A Live bacterial vaccine for controlling intestinal infection caused by clostridium difficile, preparation method thereof and application thereof
10/24/2012CN102743745A Controlled-release hepatoma cell vaccine depending on granulocyte-macrophage colony-stimulating factor (GM-CSF) wrapped by nanoparticles
10/24/2012CN102743371A Medicine for treating retinal neovascular diseases
10/24/2012CN102139103B Preparation and application methods of photobacterium damsela vaccines of cynoglossus semilaevis
10/24/2012CN101955905B Bacterial strain for producing Escherichia coli K88ac-K99-ST1-LTB quadrivalent gene engineering inactivated vaccines and inactivated vaccine production method
10/24/2012CN101549154B Compositions comprising neisseria meningitidis antigens from serogroups B and C as well as a further antigen
10/24/2012CN101469329B Compositions and methods for increasing bone mineralization
10/24/2012CN101321861B Method for generating dendritic cells employing decreased temperature
10/24/2012CN101180076B Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response
10/23/2012US8293882 Anti-tissue factor antibodies and compositions
10/23/2012US8293716 Method of treating cancer by modulation of mortalin
10/23/2012US8293528 Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus
10/23/2012US8293465 Method for the detection of human immunodeficiency virus envelope (HIV) glycoprotein utilizing carbohydrate binding module (CBM) 20 or 21
10/23/2012US8293275 Spray freeze dry of compositions for pulmonary administration
10/23/2012US8293251 Neisserial antigens
10/23/2012US8293250 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
10/23/2012US8293249 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
10/23/2012US8293248 Compositions and methods for vaccinating against HSV-2
10/23/2012US8293247 Modified influenza virus for monitoring and improving vaccine efficiency
10/23/2012US8293245 Methods and compositions based on Shiga toxin type 1 protein
10/23/2012US8293244 Phosphotriesterase from agrobacterium radiobacter p230
10/23/2012US8293243 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
10/23/2012US8293242 Ultra-high yield of alpha-1-anti-trypsin
10/23/2012US8293241 Anti-FGF19 antibodies and methods using same
10/23/2012US8293240 Method of treating drug-resistant cancer
10/23/2012US8293239 Methods of treating chronic pain
10/23/2012US8293238 GDF3 antibodies and related methods
10/23/2012US8293237 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
10/23/2012US8293236 Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism
10/23/2012US8293235 Humanization of rabbit antibodies using a universal antibody framework
10/23/2012US8293234 Antibodies which bind and inhibit blood factor VIII
10/23/2012US8293233 Method for isolation of soluble polypeptides
10/23/2012US8293232 Flowable carrier matrix and methods for delivering to a patient
10/23/2012US8293224 Attenuated uracil auxotroph of an apicomplexan and use thereof
10/23/2012US8293213 Method and apparatus for thrombus removal using magnetic particles
10/23/2012US8293206 Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment
10/23/2012CA2601006C Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
10/23/2012CA2524942C Avian e. coli vaccine for the protection against colibacillosis
10/23/2012CA2522379C The severe acute respiratory syndrome coronavirus
10/23/2012CA2469599C Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/23/2012CA2460749C Glycoconjugate vaccines for use in immune-compromised populations
10/23/2012CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
10/23/2012CA2418411C Inhibitory, monoclonal antibody against blood clotting factor vii-activating protease
10/23/2012CA2412494C Agonist anti-trk-c monoclonal antibodies
10/23/2012CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3
10/23/2012CA2366216C Polycationic carbohydrates as immunostimulants in vaccines
10/23/2012CA2361009C Her-2/neu fusion proteins
10/23/2012CA2284829C Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/23/2012CA2257839C Gamma-heregulin
10/18/2012WO2012142605A1 Rapid recolonization deployment agent
10/18/2012WO2012142434A2 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome
10/18/2012WO2012142320A2 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
10/18/2012WO2012142286A1 Methods for suppressing allergic reactions
10/18/2012WO2012141989A2 Immunogens
10/18/2012WO2012141984A1 Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
10/18/2012WO2012141280A1 Dna vaccine
10/18/2012WO2012141201A1 Peptide for cancer immunotherapy and method using same
10/18/2012WO2012140627A1 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
10/18/2012WO2012140620A1 Compositions for preventing and/or treating an infection by an hiv-1 virus
10/18/2012WO2012140424A2 Composition
10/18/2012WO2012140417A2 Combination vaccine
10/18/2012WO2012140214A1 IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
10/18/2012WO2012140171A1 Fermentation process
10/18/2012WO2012140130A1 Method for proliferation of antigen-specific t cells
10/18/2012WO2012140127A2 Method for priming of t cells
10/18/2012WO2012140109A1 Biomarkers for pain intensity
10/18/2012WO2012140068A1 New vaccines for prevention and treatment of tuberculosis
10/18/2012WO2012139281A1 Adjuvant based on hiv tat and uses thereof
10/18/2012WO2012139225A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
10/18/2012WO2012103163A3 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
10/18/2012WO2012099375A3 P47phox or p67phox-targeting therapeutic agent for stress disorders, and method for screening for same
10/18/2012WO2012088577A3 Recombinant mycobacterium sp. protein, immunodiagnostic test and tuberculosis vaccine
10/18/2012WO2012058588A3 Novel egfr-binding molecules and immunoconjugates thereof
10/18/2012US20120266264 Monoclonal antibodies against gonadotropin-releasing hormone receptor
10/18/2012US20120266262 Methods and compositions relating to zpa polypeptides
10/18/2012US20120266261 Neurovirulent strain of the west nile virus and uses thereof
10/18/2012US20120266260 Diagnosing and treating iga nephropathy
10/18/2012US20120264625 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/18/2012US20120264172 Protein from Photobacterium Damselae and Use Thereof
10/18/2012US20120263782 Methods and compositions for treating hiv infection
10/18/2012US20120263781 Methods and compositions for treating rhinitis
10/18/2012US20120263779 Biodegradable drug delivery system
10/18/2012US20120263764 Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease
10/18/2012US20120263757 Composition and method for diagnosis and immunotherapy of prostate cancer
10/18/2012US20120263756 Vaccines containing canine parvovirus genetic variants
10/18/2012US20120263755 Methods and compositions for eliciting an immune response against hepatitis b virus
10/18/2012US20120263753 Benzonaphthyridine-containing vaccines
10/18/2012US20120263752 Herpes Simplex Virus Vaccines
10/18/2012US20120263751 Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections
10/18/2012US20120263750 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites
10/18/2012US20120263749 Polyvalent conjugate vaccine for cancer
10/18/2012US20120263748 Superior Molecular Vaccine Linking the Translocation Domain of a Bacterial Toxin to an Antigen
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263746 Use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease
10/18/2012US20120263745 Antichlamydial agents
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 1823